Showing results (1931-1940 of 1,948) with videos related to
Sort By:
Pageof 195
Cancer Cell|December 10, 2014
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancersPradeep Chaluvally-Raghavan, Fan Zhang, Sunila Pradeep, et al.Cell Reports|December 7, 2017
Differential Effects of EGFL6 on Tumor versus Wound AngiogenesisKyunghee Noh, Lingegowda S Mangala, Hee-Dong Han, et al.Cancer Cell|July 16, 2014
Hematogenous metastasis of ovarian cancer: rethinking mode of spreadSunila Pradeep, Seung W Kim, Sherry Y Wu, et al.Science (New York, N.Y.)|September 7, 2023
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitorsXiangdong Lv, Xuan Lu, Jin Cao, et al.The New England Journal of Medicine|February 17, 2012
Paraneoplastic thrombocytosis in ovarian cancerRebecca L Stone, Alpa M Nick, Iain A McNeish, et al.Nature Communications|September 11, 2013
Tumour angiogenesis regulation by the miR-200 familyChad V Pecot, Rajesha Rupaimoole, Da Yang, et al.Cancer Research|April 18, 2018
Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF InductionJulie K Allen, Guillermo N Armaiz-Pena, Archana S Nagaraja, et al.Nature Communications|July 11, 2025
Oral dosing of the nucleoside analog obeldesivir is efficacious against RSV infection in African green monkeysJared Pitts, J Lizbeth Reyes Zamora, Savrina Manhas, et al.Genome Biology|November 28, 2019
Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancersJason K Sa, Jae Ryoung Hwang, Young-Jae Cho, et al.Nature Communications|March 13, 2014
2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activitySherry Y Wu, Xianbin Yang, Kshipra M Gharpure, et al.Pageof 195